Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail

Otsuka Obtains Global Rights To Two Drugs

 
• By Lisa Takagi
  
Sumitomo decided to prioritize other candidates than the four in the Otsuka deal amid financial challenges.
Sumitomo has decided to prioritize other R&D candidates over the four in its Otsuka alliance amid financial challenges • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip